Truqap Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

TRUQAP 160 mg: TRUQAP 160 mg tablets are round, biconvex, beige, film-coated tablets debossed with 'CAV' above '160' on one side and plain on the reverse.
Each film-coated tablet contains 160 mg of capivasertib.
TRUQAP 200 mg: TRUQAP 200 mg are capsule-shaped, biconvex, beige film-coated tablets debossed with 'CAV 200' on one side and plain on the reverse.
Each film-coated tablet contains 200 mg of capivasertib.
Excipients/Inactive Ingredients: Tablet core: Microcrystalline cellulose, Dibasic calcium phosphate, Croscarmellose sodium, Magnesium stearate.
Tablet coating: Hypromellose, Titanium dioxide, Polyethylene glycol 3350, Polydextrose, Copovidone, Medium chain triglycerides, Yellow iron oxide, Red iron oxide, Black iron oxide.

Manufacturer:

AstraZeneca

Distributor:

Zuellig Pharma